Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Ovarian Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Thymus Neoplasms 1 Shoulder Disease 1 Neuroblastoma 1 Neoplasms 1 Neoplasm Metastasis 1 Mesothelioma 1 Margins of Excision 1 Lung Neoplasms 1 Kidney Neoplasms 1 Hernia, Hiatal 1 Gastroesophageal Reflux 1 Esophageal Neoplasms 1 Esophageal Diseases 1 Esophageal Achalasia 1 Craniopharyngioma 1 Colonic Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Hepatocellular 1 Breast Cancer Female 1 Adenocarcinoma 1

Interventions

Sunitinib 26 Everolimus 20 Bevacizumab 19 aldesleukin 18 Sorafenib 16 Nivolumab 16 Interleukin-2 14 pembrolizumab 13 Peripheral Blood Stem Cell Transplantation 13 fludarabine phosphate 12 Radiotherapy 12 Interferon-alpha 12 Cyclophosphamide 12 Radiosurgery 11 Filgrastim 11 Blood Specimen Collection 11 Ipilimumab 10 Gemcitabine 10 Axitinib 9 Surveys and Questionnaires 7 Gene Expression Profiling 7 Cryosurgery 7 temsirolimus 6 pazopanib 6 Surgical Procedures, Operative 6 durvalumab 5 cabozantinib 5 atezolizumab 5 Mycophenolic Acid 5 Immunohistochemistry 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Kidney Neoplasms × Tumor Burden × Clear all

NCT04005820 2019-07-02

UMBRELLA

Assistance Publique Hopitaux De Marseille

Phase NA Not yet recruiting

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡